150 related articles for article (PubMed ID: 28765339)
41. Lipid biomarkers and long-term risk of cancer in the Women's Health Study.
Chandler PD; Song Y; Lin J; Zhang S; Sesso HD; Mora S; Giovannucci EL; Rexrode KE; Moorthy MV; Li C; Ridker PM; Lee IM; Manson JE; Buring JE; Wang L
Am J Clin Nutr; 2016 Jun; 103(6):1397-407. PubMed ID: 27099252
[TBL] [Abstract][Full Text] [Related]
42. Alcohol Use and Breast Cancer Survival among Participants in the Women's Health Initiative.
Lowry SJ; Kapphahn K; Chlebowski R; Li CI
Cancer Epidemiol Biomarkers Prev; 2016 Aug; 25(8):1268-73. PubMed ID: 27197280
[TBL] [Abstract][Full Text] [Related]
43. Calcium Channel Blockers and Risk of Lymphedema among Breast Cancer Patients: Nested Case-Control Study.
Stolarz AJ; Lakkad M; Klimberg VS; Painter JT
Cancer Epidemiol Biomarkers Prev; 2019 Nov; 28(11):1809-1815. PubMed ID: 31399477
[TBL] [Abstract][Full Text] [Related]
44. Statin use and breast cancer: prospective results from the Women's Health Initiative.
Cauley JA; McTiernan A; Rodabough RJ; LaCroix A; Bauer DC; Margolis KL; Paskett ED; Vitolins MZ; Furberg CD; Chlebowski RT;
J Natl Cancer Inst; 2006 May; 98(10):700-7. PubMed ID: 16705124
[TBL] [Abstract][Full Text] [Related]
45. Calcium channel blocker use reduces incident dementia risk in elderly hypertensive patients: A meta-analysis of prospective studies.
Hussain S; Singh A; Rahman SO; Habib A; Najmi AK
Neurosci Lett; 2018 Apr; 671():120-127. PubMed ID: 29452176
[TBL] [Abstract][Full Text] [Related]
46. Calcium channel blockers versus other classes of drugs for hypertension.
Chen N; Zhou M; Yang M; Guo J; Zhu C; Yang J; Wang Y; Yang X; He L
Cochrane Database Syst Rev; 2010 Aug; (8):CD003654. PubMed ID: 20687074
[TBL] [Abstract][Full Text] [Related]
47. Calcium Channel Blocker Use and Risk of Prostate Cancer by TMPRSS2:ERG Gene Fusion Status.
Geybels MS; McCloskey KD; Mills IG; Stanford JL
Prostate; 2017 Feb; 77(3):282-290. PubMed ID: 27753122
[TBL] [Abstract][Full Text] [Related]
48. Beta-blockers for hypertension.
Wiysonge CS; Bradley H; Mayosi BM; Maroney R; Mbewu A; Opie LH; Volmink J
Cochrane Database Syst Rev; 2007 Jan; (1):CD002003. PubMed ID: 17253471
[TBL] [Abstract][Full Text] [Related]
49. Management of periodontal disease in patients using calcium channel blockers - gingival overgrowth, prescribed medications, treatment responses and added treatment costs.
Fardal Ø; Lygre H
J Clin Periodontol; 2015 Jul; 42(7):640-6. PubMed ID: 26076712
[TBL] [Abstract][Full Text] [Related]
50. Lower dementia risk with different classes of antihypertensive medication in older patients.
van Middelaar T; van Vught LA; Moll van Charante EP; Eurelings LSM; Ligthart SA; van Dalen JW; van den Born BJH; Richard E; van Gool WA
J Hypertens; 2017 Oct; 35(10):2095-2101. PubMed ID: 28509727
[TBL] [Abstract][Full Text] [Related]
51. Influence of physician specialty on adoption and relinquishment of calcium channel blockers and other treatments for myocardial infarction.
Majumdar SR; Inui TS; Gurwitz JH; Gillman MW; McLaughlin TJ; Soumerai SB
J Gen Intern Med; 2001 Jun; 16(6):351-9. PubMed ID: 11422631
[TBL] [Abstract][Full Text] [Related]
52. Metabolic syndrome risk components and mortality after triple-negative breast cancer diagnosis in postmenopausal women in the Women's Health Initiative.
Yuan Y; Pan K; Mortimer J; Chlebowski RT; Luo J; Yan JE; Yost SE; Kroenke CH; Adams-Campbell L; Nassir R; Sun Y; Shadyab AH; Vitolins MZ; Saquib N; Wild RA; Manson JE; Nelson RA
Cancer; 2021 May; 127(10):1658-1667. PubMed ID: 33476042
[TBL] [Abstract][Full Text] [Related]
53. The Combined Association of Modifiable Risk Factors with Breast Cancer Risk in the Women's Health Initiative.
Arthur R; Wassertheil-Smoller S; Manson JE; Luo J; Snetselaar L; Hastert T; Caan B; Qi L; Rohan T
Cancer Prev Res (Phila); 2018 Jun; 11(6):317-326. PubMed ID: 29483073
[TBL] [Abstract][Full Text] [Related]
54. Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial.
Anderson GL; Chlebowski RT; Aragaki AK; Kuller LH; Manson JE; Gass M; Bluhm E; Connelly S; Hubbell FA; Lane D; Martin L; Ockene J; Rohan T; Schenken R; Wactawski-Wende J
Lancet Oncol; 2012 May; 13(5):476-86. PubMed ID: 22401913
[TBL] [Abstract][Full Text] [Related]
55. Clinical outcomes between calcium channel blockers and angiotensin receptor blockers in hypertensive patients without established cardiovascular diseases during a 3-year follow-up.
Jeong HS; Lim HS; Park HJ; Lee WS; Choi JO; Lee HS; Jo SH; Hong SJ
Sci Rep; 2021 Jan; 11(1):1783. PubMed ID: 33469103
[TBL] [Abstract][Full Text] [Related]
56. Chocolate Candy and Incident Invasive Cancer Risk in the Women's Health Initiative: An Observational Prospective Analysis.
Greenberg JA; Neuhouser ML; Tinker LF; Lane DS; Paskett ED; Van Horn LV; Wassertheil-Smoller S; Shikany JM; Qi L; Sealy-Jefferson S; Manson JE
J Acad Nutr Diet; 2021 Feb; 121(2):314-326.e4. PubMed ID: 32763064
[TBL] [Abstract][Full Text] [Related]
57. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
[TBL] [Abstract][Full Text] [Related]
58. Breast cancer in postmenopausal women after non-melanomatous skin cancer: the Women's Health Initiative observational study.
Pressler M; Rosenberg CA; Derman BA; Greenland P; Khandekar J; Rodabough RJ; McTiernan A; Simon MS
Breast Cancer Res Treat; 2013 Jun; 139(3):821-31. PubMed ID: 23760856
[TBL] [Abstract][Full Text] [Related]
59. Calcium channel blocker use and risk of Parkinson's disease.
Simon KC; Gao X; Chen H; Schwarzschild MA; Ascherio A
Mov Disord; 2010 Sep; 25(12):1818-22. PubMed ID: 20669249
[TBL] [Abstract][Full Text] [Related]
60. Cardiovascular disease and mortality after breast cancer in postmenopausal women: Results from the Women's Health Initiative.
Park NJ; Chang Y; Bender C; Conley Y; Chlebowski RT; van Londen GJ; Foraker R; Wassertheil-Smoller S; Stefanick ML; Kuller LH
PLoS One; 2017; 12(9):e0184174. PubMed ID: 28934233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
